Head and Neck Squamous Cell Carcinoma (HNSCC) Recruiting Phase 1 / 2 Trials for DB00515 (Cisplatin)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02901483A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck CancerTreatment